Global Custom Market Research Reports Provider Company

phone

Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review

  • Published Date: 05 Dec 2017
  • Number of Pages: 42
  • Category: Pharmaceuticals
  • Country: United States of America
Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description A detailed description of the companys operations and business divisions.
- Corporate strategy Analysts summarization of the companys business strategy.
- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history Progression of key events associated with the company.
- Major products and services A list of major products, services and brands of the company.
- Key competitors A list of key competitors to the company.
- Key employees A list of the key executives of the company.
- Executive biographies A brief summary of the executives employment history.
- Key operational heads A list of personnel heading key departments/functions.
- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Flexion Therapeutics Inc (Flexion) is a pharmaceutical company that develops and commercializes pain therapies. The companys products comprise FX006, FX007, and FX005. Its FX005 is a p38 mitogen-activated protein, kinase inhibitor that contains both analgesic and anti-inflammatory properties. It provides FX006, an injectable, intra-articular, sustained release drug to provide long lasting, local analgesia. The company offers FX007, a preclinical, small molecule TrkA receptor antagonist designed to treat post-operative pain. It offers anti-inflammatory and analgesic therapies for osteoarthritis. Flexion is headquartered in Burlington, Massachusetts, the US.

Flexion Therapeutics Inc Key Recent Developments

Nov 06,2017: Flexion Therapeutics Reports Third-Quarter 2017 Financial Results and Recent Business Highlights
Aug 08,2017: Flexion Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights
Jun 28,2017: Flexion Therapeutics appoints new senior vice president, general counsel and secretary
May 04,2017: Flexion Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Highlights
Apr 07,2017: Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The companys core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
Publisher Name : GlobalData
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 - About the Company 5
Flexion Therapeutics Inc - Key Facts 5
Flexion Therapeutics Inc - Key Employees 6
Flexion Therapeutics Inc - Key Employee Biographies 7
Flexion Therapeutics Inc - Major Products and Services 8
Flexion Therapeutics Inc - History 9
Flexion Therapeutics Inc - Company Statement 10
Flexion Therapeutics Inc - Locations And Subsidiaries 12
Head Office 12
Other Locations & Subsidiaries 12
Section 2 Company Analysis 13
Flexion Therapeutics Inc - Business Description 13
R&D Overview 13
Flexion Therapeutics Inc - SWOT Analysis 14
SWOT Analysis - Overview 14
Flexion Therapeutics Inc - Strengths 14
Flexion Therapeutics Inc - Weaknesses 15
Flexion Therapeutics Inc - Opportunities 16
Flexion Therapeutics Inc - Threats 17
Flexion Therapeutics Inc - Key Competitors 18
Section 3 Company Financial Ratios 19
Financial Ratios - Capital Market Ratios 19
Financial Ratios - Annual Ratios 20
Performance Chart 22
Financial Performance 22
Financial Ratios - Interim Ratios 23
Financial Ratios - Ratio Charts 24
Section 4 Companys Lifesciences Financial Deals and Alliances 25
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Flexion Therapeutics Inc, Recent Deals Summary 27
Section 5 Companys Recent Developments 28
Nov 06, 2017: Flexion Therapeutics Reports Third-Quarter 2017 Financial Results and Recent Business Highlights 28
Aug 08, 2017: Flexion Therapeutics Reports Second Quarter 2017 Financial Results and Recent Business Highlights 29
Jun 28, 2017: Flexion Therapeutics appoints new senior vice president, general counsel and secretary 30
May 04, 2017: Flexion Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Highlights 31
Apr 07, 2017: Flexion Therapeutics Announces Appointment of Yamo Deniz, MD, as Chief Medical Officer 32
Mar 09, 2017: Flexion Reports Year-End 2016 Financial Results 33
Nov 07, 2016: Flexion Therapeutics Reports Third Quarter 2016 Financial Results 34
Sep 29, 2016: Flexion Therapeutics Announces Appointment of John Magee as Vice President of Sales 35
Sep 14, 2016: Flexion Therapeutics Announces Appointment of Mark Stejbach to its Board of Directors 36
Sep 14, 2016: Flexion Therapeutics Announces Appointment of Mark Stejbach to its Board of Directors 37
Section 6 Appendix 38
Methodology 38
Ratio Definitions 38
About GlobalData 42
Contact Us 42
Disclaimer 42

List Of Tables


Flexion Therapeutics Inc, Key Facts 5
Flexion Therapeutics Inc, Key Employees 6
Flexion Therapeutics Inc, Key Employee Biographies 7
Flexion Therapeutics Inc, Major Products and Services 8
Flexion Therapeutics Inc, History 9
Flexion Therapeutics Inc, Subsidiaries 12
Flexion Therapeutics Inc, Key Competitors 18
Flexion Therapeutics Inc, Ratios based on current share price 19
Flexion Therapeutics Inc, Annual Ratios 20
Flexion Therapeutics Inc, Annual Ratios (Cont...1) 21
Flexion Therapeutics Inc, Interim Ratios 23
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 26
Flexion Therapeutics Inc, Recent Deals Summary 27
Currency Codes 38
Capital Market Ratios 38
Equity Ratios 39
Profitability Ratios 39
Cost Ratios 40
Liquidity Ratios 40
Leverage Ratios 41
Efficiency Ratios 41

List Of Figures


Flexion Therapeutics Inc, Performance Chart (2012 - 2016) 22
Flexion Therapeutics Inc, Ratio Charts 24
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 25
Flexion Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 26

Flexion Therapeutics Inc (FLXN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile has been compiled by

View Report

data on the number of deals and their value categorized into deal

View Report
There is no reviews available for this report

Select License Type

Delivery Details

Delivery Details : Electronic files (PDF) of market research reports will dispatched within 12 to 24 hours. (Mon-Fri IST)

Customized Report

If a particular report is not as per your requirement you can ‎choose "Customized Report". To visit click on -

Custom Research Reports